Market research
CTEC.LSE ConvaTec Group Plc
LSE GBP Healthcare
Latest close
As of 30 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 5B
- P/E ratio
- 48.76
- Analyst target
- 301.8023
- Dividend yield
- 3.1%
- Beta
- 0.77
Profile
Instrument facts
- Exchange
- LSE
- Currency
- GBP
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- ISIN
- GB00BD3VFW73
- Market cap
- 5B
- P/E ratio
- 48.76
- Analyst target
- 301.8023
- Dividend yield
- 3.1%
- Beta
- 0.77
About
About ConvaTec Group Plc
Convatec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies for the management of chronic conditions in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, bladder cancer, inflammatory bowel disease, and trauma. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, neurological disease, prostate enlargement or other causes. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for use in continuous infusion treatments for conditions such as Parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. Convatec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.
Research context
ConvaTec Group Plc appears in PyInvesting’s London Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- GBP
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the CTEC.LSE discussion.
5 years, 6 months ago
ConvaTec Group Plc is currently in a long term uptrend where the price is trading 22.2% above its 200 day moving average.
From a valuation standpoint, the stock is 99.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.8.
ConvaTec Group Plc's total revenue sank by 0.0% to $469M since the same quarter in the previous year.
Its net income has dropped by 0.0% to $-17M since the same quarter in the previous year.
Finally, its free cash flow grew by 9.9% to $97M since the same quarter in the previous year.
Based on the above factors, ConvaTec Group Plc gets an overall score of 3/5.